Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,240,210
+$1,240,210 QoQ
Shares Held
1,034
Ownership
0.000%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#2,936
of 4,605 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in LLY
reported options exposure · as of Dec 31, 2025CallValue
$6,340,612
CallShares
5,900
PutValue
$5,695,804
PutShares
5,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Volterra Technologies LP holds $2,250,077 across 2 Drug Manufacturers - General names. LLY ranks #1 (55.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,034 | $1,240,210 | |
| 2 | PFE |
Pfizer Inc
|
41,938 | $1,009,867 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,240,210 | 1,034 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $6,340,612 | 5,900 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $5,695,804 | 5,300 | Put | Sole | 2026-02-13 | |
| 2025-06-30 | $623,624 | 800 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $545,671 | 700 | Call | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||